Literature DB >> 891903

Polymorphism of rifampicin.

G Pelizza, M Nebuloni, P Ferrari, G G Gallo.   

Abstract

The antibiotic rifampicin shows polymorphism. Two crystalline forms, an amorphous form and four solvates (S I and S II from water; S III from tetrahydrofuran; S IV from carbon tetachloride) have been isolated and characterized by thermal analysis, infrared and X-ray powder spectroscopy. The functional I.R. bands have been interpreted as indicative of some structural features involved in the polymorphism: the intramolecular H-bonds between C23--OH and O=C--O--C25, C4--OH and O=C11, and C1--OH and O=C15. The relative physical stabilities of the various forms are reported.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 891903

Source DB:  PubMed          Journal:  Farmaco Sci        ISSN: 0430-0920


  3 in total

1.  HPMA-PLGA Based Nanoparticles for Effective In Vitro Delivery of Rifampicin.

Authors:  Sarita Rani; Avinash Gothwal; Pawan K Pandey; Devendra S Chauhan; Praveen K Pachouri; Umesh D Gupta; Umesh Gupta
Journal:  Pharm Res       Date:  2018-12-03       Impact factor: 4.200

2.  Powder properties and their influence on dry powder inhaler delivery of an antitubercular drug.

Authors:  Vasu V Sethuraman; Anthony J Hickey
Journal:  AAPS PharmSciTech       Date:  2002       Impact factor: 3.246

3.  In vitro release kinetics of antituberculosis drugs from nanoparticles assessed using a modified dissolution apparatus.

Authors:  Yuan Gao; Jieyu Zuo; Nadia Bou-Chacra; Terezinha de Jesus Andreoli Pinto; Sophie-Dorothee Clas; Roderick B Walker; Raimar Löbenberg
Journal:  Biomed Res Int       Date:  2013-07-10       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.